ViClarity Launches AI-Powered Reg Monitor to Turn Regulatory Updates into Actionable, Audit-Ready Workflows for Compliance Teams April 8, 2026 New regulatory horizon scanning capability helps compliance teams identify relevant federal and state updates and manage implementation through centralized, auditable workflows
Tractive Launches Next-Generation Health Intelligence for Pets, Revolutionizing Connected Pet Care April 8, 2026 The all-new DOG 6 XL debuts alongside CAT 6 Mini, Tractive's first-ever collar-integrated GPS and health tracker built specifically for cats, and enhanced Tractive app capabilities.
Blackline Safety Enters into Definitive Agreement to be Acquired by Francisco Partners for up to $850 Million April 8, 2026 Shareholders to Receive $9.00 Cash Per Share Plus a Contingent Value Right of up to $0.50 Per Share $9.00 Cash Consideration per Share and up to $9.50 Total Consideration per Share represents a 28% and 35% premium to the 20-day VWAP of Blackline’s Shares on the TSX as of April 7, 2026 The cash-plus-CVR structure provides immediate value and liquidity for Shareholders while preserving the opportunity to potentially receive an additional cash payment if the Company achieves its near-term ARR target Voting support agreements have been entered into by certain shareholders, as well as Blackline’s directors and senior officers, representing approximately 34% of the outstanding Shares, including irrevocable voting support agreements from several of the Company’s largest shareholders representing approximately 30% of the outstanding Shares Blackline’s largest shareholder, DAK Capital Inc., owned by Daryl Katz, has agreed to exchange all of its Shares for shares of the Purchaser Board unanimously recommends Shareholders vote in favour of the Transaction
Instagram account featuring Faf de Klerk recruiting players for North Korea April 8, 2026 North Korea is looking to attract British English teachers by enticing them to the dictatorial state with the promise of elite rugby contracts. A social media account that features a similar recruitment drive for Chinese rugby has posted an advert, seeking rugby players for the People’s Democratic Republic of Korea (North Korea)’s Pyongyang Reds team. [...]
Reply Selected by Microsoft as Launch Partner for Agent 365, Supporting the Governance and Scaling of AI agents April 8, 2026 Reply [EXM, STAR: REY] has been confirmed one of a small number of Launch Partners for Agent 365, supporting the general availability of Microsoft’s new platform designed to provide enterprise-grade governance, observability and lifecycle management for AI agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408212380/en/ Microsoft Agent 365 introduces a structured [...]
Motive Launches AI-Powered Motive Analytics to Transform How UK Teams Leverage Data, Turning Hours of Analysis Into Real-Time Insights in Seconds April 8, 2026 No more wasting hours combing through hard-to-read databases and reports—new AI-powered analytics solution designed to help teams gain instant insights so they can make better decisions faster Includes a conversational AI for physical operations designed to instantly surface answers from the full range of operational data Motive brings together across the organisation
UK Investors Back Narwhal Labs With £20 Million Investment to Launch DeepBlue Enterprise-Grade Agentic AI April 8, 2026 - Purpose-built for regulated enterprise and government use, DeepBlue OS turns missed customer leads into revenue, deployable in minutes with no setup cost
Londonmaxxing could save the capital’s jobs market April 8, 2026 Can Londonmaxxing help revive the capital's flailing job market? Employment expert Kevin Fitzgerald thinks so.
Jeito Capital Hits Record $1.2 Billion (€1 Billion)1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients April 8, 2026 This record closing is the largest raise ever achieved by a fully independent European fund dedicated to Biopharma, validating Jeito’s patient-driven investment strategy, its multidisciplinary, collaborative expertise spanning from science to commercialization of medicines, and value creation In five years, Jeito Capital has tripled its assets under management to €1.6 billion, firmly establishing itself among the top-tier global Biopharma investors Jeito II will build on Jeito I’s proven and differentiated strategy, investing in the most promising clinical Biopharma companies which address unmet patient needs and severe diseases, accelerate breakthrough therapeutic innovation, and deliver transformative benefits for patients This fundraise represents significant momentum for European Biopharma, strengthening its financial firepower and expertise to develop the next generation of global champions
M&A in a time of geopolitical turmoil April 8, 2026 Dealmakers are being more selective and concentrating their bets to cope with AI, tariffs and instability in the Middle East, says Jerome Pottier A trillion dollars of dealmaking in under three months should feel like a boom. By the numbers, it is. Activity is up 27 per cent year on year, and the megadeal is [...]